|

CDK 4/6 inhibitors Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Region Örebro County1

Indications

  • Older Patients1
  • Toxicity1
  • Metastatic Breast Cancer1
  • Advanced Breast Cancer1
  • Quality of Life1

Other1 trial

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.